[HTML][HTML] Current indication and practical management of percutaneous left ventricular assist device support therapy in Japan
M Nakamura, T Imamura, H Ueno, K Kinugawa - Journal of Cardiology, 2020 - Elsevier
Abstract Impella (Abiomed, Danvers, MA, USA) is a recently-innovated (commercially
available from 2017 in Japan) percutaneous left ventricular assist device which is inserted …
available from 2017 in Japan) percutaneous left ventricular assist device which is inserted …
Multi-indicator analysis of mechanical blood damage with five clinical ventricular assist devices
Purpose Device-induced blood damage contributes the hemolysis, thrombosis and bleeding
complications in patients supported with ventricular assist device (VAD). This study aims to …
complications in patients supported with ventricular assist device (VAD). This study aims to …
Echocardiographic imaging of temporary percutaneous mechanical circulatory support devices
T Tran, P Mudigonda, C Mahr, J Kirkpatrick - Journal of Echocardiography, 2022 - Springer
Cardiogenic shock is a state of end-organ hypoperfusion due to primary cardiac dysfunction
and portends a poor prognosis. Shock refractory to inotropic and vasopressor support is …
and portends a poor prognosis. Shock refractory to inotropic and vasopressor support is …
Impella support as a bridge to scheduled surgical repair of ventricular septal rupture
M Nakamura, T Imamura, T Fukui, Y Ueno… - Journal of Artificial …, 2020 - Springer
We studied the experience of a 69-year-old woman with acute decompensated heart failure
due to post-infarction ventricular septal rupture. She received mechanical hemodynamic …
due to post-infarction ventricular septal rupture. She received mechanical hemodynamic …